A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Purpose An optimal target for glucose control in ICU patients remains unclear. This prospective randomized controlled trial compared the effects on ICU mortality of intensive insulin therapy (IIT) with an intermediate glucose control. Methods Adult patients admitted to the 21 participating medico-surgical ICUs were randomized to group 1 (target BG 7.8-10.0 mmol/L) or to group 2 (target BG 4.4-6.1 mmol/L). Results While the required sample size was 1,750 per group, the trial was stopped early due to a high rate of unintended protocol violations. From 1,101 admissions, the outcomes of 542 patients assigned to group 1 and 536 of group 2 were analysed. The groups were well balanced. BG levels averaged in group 1 8.0 mmol/L (IQR 7.1-9.0) (median of all values) and 7.7 mmol/L (IQR 6.7-8.8) (median of morning BG) versus 6.5 mmol/L (IQR 6.0-7.2) and 6.1 mmol/L (IQR 5.5-6.8) for group 2 (p Conclusions In this prematurely stopped and therefore underpowered study, there was a lack of clinical benefit of intensive insulin therapy (target 4.4-6.1 mmol/L), associated with an increased incidence of hypoglycaemia, as compared to a 7.8-10.0 mmol/L target. (ClinicalTrials.gov # NCT00107601, EUDRA-CT Number: 200400391440).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A retrospective study suggested that tidal volumes should be lowered even with plateau pressures ≤ 30 cm H 2 O (431) because lower plateau pressures were associated with reduced hospital mortality (432).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [431]
In the citing paper
“In the surgical ICU, earlier studies have indicated that intensive glucose control (80 to 110 mg/dL) inconsistently resulted in decreased length of stay.94–96”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Intensive glycemic control post-operatively, compared to less intensive targets, has resulted in equivocal or mixed results; however, other studies have shown no benefits.94,100,101,104”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Obese patients are only slightly more prevalent in the ICU than in the hospital and in the related populations.”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
In the citing paper
“There is a large variability in the prevalence between countries with more than 39% and 37% obese (BMI>30 kg/m 2 ) present in the US ICUs and hospital wards, 22% and 19% in Europe, 17% and 14% in South America and 10% and 7% in the Asian and Pacific region based on data from the Nutrition Day project (6,351).”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“The Acute Physiological and Chronic Health Evaluation (APACHE II) on admission [11] and the daily Sequential Organ Failure Assessment (SOFA) [12] scores and the presence of diabetes were recorded.”
MethodVincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674 · cited 9×
“The overall severity of organ failures assessed by daily SOFA scores were similar in both groups as were the other severity indices of illness, the number of febrile days and the number of days with anti-infective agents, except for the number of patient days with vasopressors/inotropes which was higher in the group 2…”
MethodInfluentialIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 1×
“Nevertheless, the mortality was slightly and not significantly increased in the group 2, consistently with other recent prospective trials [7, 14, 18, 19].”
ResultIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 9×
“The proportion of time in range calculated from morning BG values was not lower than in the most of the other studies [6, 7, 13, 17].”
BackgroundMethodResultInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Riker, R. R. (2009) · JAMA · doi:10.1001/jama.2009.56 · Cited by 1,672
Dungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Self-citationKrinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165 · cited 1×
“with other recent findings [14, 25].”
Research works printed but not linked: 2
- Devos P, Preiser JC, Melot C (2007) Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. Intensive Care Med 33:S189
- Devos P, Ledoux D, Preiser JC (2005) Current practice of glycaemia control in European intensive care units (ICUS). Intensive Care Med 31:S203
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Self-citationThe Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Self-citationSurviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
“The continuation of insulin infusions, especially with the cessation of nutrition, has been identified as a risk factor for hypoglycemia [454].”
BackgroundSelf-citationSurviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Self-citationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
ESPEN guideline on clinical nutrition in the intensive care unit.
Singer, P., Blaser, A. R., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., Hiesmayr, M., Mayer, K., Montejo, J. C., Pichard, C., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.037 · Cited by 2,904
Self-citationDeakin, C. D., Nolan, J. P., Soar, J., Sunde, K., Koster, R. W., Smith, G. B., & Perkins, G. D. (2010) · Resuscitation · doi:10.1016/j.resuscitation.2010.08.017 · Cited by 2,700
Peberdy, M. A., Callaway, C. W., Neumar, R. W., Geocadin, R. G., Zimmerman, J. L., Donnino, M., Gabrielli, A., Silvers, S. M., Zaritsky, A. L., Merchant, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.971002 · Cited by 2,522
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004363 · Cited by 1,565
European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary
Nolan, J. P., Soar, J., Zideman, D. A., Biarent, D., Bossaert, L. L., Deakin, C., Koster, R. W., Wyllie, J., & Böttiger, B. (2010) · Resuscitation · doi:10.1016/j.resuscitation.2010.08.021 · Cited by 1,375
Umpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
Hypoglycemia and risk of death in critically ill patients
The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Nelson, G., Altman, A. D., Nick, A., Meyer, L. A., Ramirez, P. T., Achtari, C., Antrobus, J., Huang, J., Scott, M., Wijk, L., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.12.019 · Cited by 562
Jacobi, J., Bircher, N., Krinsley, J., Agus, M., Braithwaite, S. S., Deutschman, C., Freire, A. X., Geehan, D., Kohl, B., Nasraway, S. A., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182653269 · Cited by 571
“The rates of hypoglycemia are above 10% for many protocols using BG checks every 4 hrs (1, 14, 15, 17).”
BackgroundInfluentialHandelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
Iskander, K. N., Osuchowski, M. F., Stearns-Kurosawa, D. J., Kurosawa, S., Stepien, D., Valentine, C., & Remick, D. G. (2013) · Physiological Reviews · doi:10.1152/physrev.00037.2012 · Cited by 453
Arabi, Y. M., Dabbagh, O. C., Tamim, H. M., Al-Shimemeri, A. A., Memish, Z. A., Haddad, S. H., Syed, S. J., Giridhar, H. R., Rishu, A. H., Al-Daker, M. O., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818f21aa · Cited by 471
Glucose variability is associated with intensive care unit mortality*
Hermanides, J., Vriesendorp, T. M., Bosman, R. J., Zandstra, D. F., Hoekstra, J. B., & DeVries, J. H. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cc4be9 · Cited by 437
“GV was not reported as an outcome measure in the Leuven studies, the GluControl study, the Volume Substitution and Insulin Therapy in Severe Sepsis study, and the Normoglycemia in Intensive Care Evaluation–Survival Using Glucose Algorithm Regulation study (1, 2, 4, 7, 8).”
ResultHypoglycemia and outcome in critically ill patients
Egi, M., Bellomo, R., Stachowski, E., French, C. J., Hart, G. K., Taori, G., Hegarty, C., & Bailey, M. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0394 · Cited by 432
The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill
Friedrich, O., Reid, M. B., Van den Berghe, G., Vanhorebeek, I., Hermans, G., Rich, M. M., & Larsson, L. (2015) · Physiological Reviews · doi:10.1152/physrev.00028.2014 · Cited by 396
Krinsley, J. S., Egi, M., Kiss, A., Devendra, A. N., Schuetz, P., Maurer, P. M., Schultz, M. J., van Hooijdonk, R. T., Kiyoshi, M., Mackenzie, I. M., et al. (2013) · Critical Care · doi:10.1186/cc12547 · Cited by 369
“One possible explanation for the divergent results among such trials may relate to the incidence of severe hypoglycemia sustained by patients in the interventional arms of randomized trials [6-11].”
ResultSelf-citationToward Understanding Tight Glycemic Control in the ICU
Marik, P. E., & Preiser, J.-C. (2010) · Chest · doi:10.1378/chest.09-1737 · Cited by 365
Self-citationJoannidis, M., Druml, W., Forni, L. G., Groeneveld, A. B. J., Honore, P. M., Hoste, E., Ostermann, M., Oudemans-van Straaten, H. M., & Schetz, M. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4832-y · Cited by 340
Self-citationNyenwe, E. A., Jerkins, T. W., Umpierrez, G. E., & Kitabchi, A. E. (2011) · Metabolism · doi:10.1016/j.metabol.2010.09.010 · Cited by 343
“[79] Preiser JC, Devos P, Ruiz-Santana S, et al.”
InfluentialQaseem, A., Humphrey, L. L., Chou, R., Snow, V., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-4-201102150-00007 · Cited by 334
Umpierrez, G., Cardona, S., Pasquel, F., Jacobs, S., Peng, L., Unigwe, M., Newton, C. A., Smiley-Byrd, D., Vellanki, P., Halkos, M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0303 · Cited by 281
ESPEN guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease
Fiaccadori, E., Sabatino, A., Barazzoni, R., Carrero, J. J., Cupisti, A., De Waele, E., Jonckheer, J., Singer, P., & Cuerda, C. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.01.028 · Cited by 277
Self-citationTight Glycemic Control versus Standard Care after Pediatric Cardiac Surgery
Agus, M. S. D., Steil, G. M., Wypij, D., Costello, J. M., Laussen, P. C., Langer, M., Alexander, J. L., Scoppettuolo, L. A., Pigula, F. A., Charpie, J. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206044 · Cited by 274
Rosenberger, L. H., Politano, A. D., & Sawyer, R. G. (2011) · Surgical Infections · doi:10.1089/sur.2010.083 · Cited by 267
Intensive Insulin Therapy in Hospitalized Patients: A Systematic Review
Kansagara, D., Fu, R., Freeman, M., Wolf, F., & Helfand, M. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-4-201102150-00008 · Cited by 255
“Preiser et al, 2009 (41) Both groups: insulin infusion*† TG: 4.”
InfluentialThe GRADE system for rating clinical guidelines
Kavanagh, B. P. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000094 · Cited by 246
Hypoglycemia is associated with intensive care unit mortality*
Hermanides, J., Bosman, R. J., Vriesendorp, T. M., Dotsch, R., Rosendaal, F. R., Zandstra, D. F., Hoekstra, J. B. L., & DeVries, J. H. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181de562c · Cited by 236
“Two large multicenter randomized controlled trials were carried out to confirm these results but were terminated prematurely because of high rates of severe hypoglycemia or because the target glucose range was not reached (4, 5).”
BackgroundDysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality
Plummer, M. P., Bellomo, R., Cousins, C. E., Annink, C. E., Sundararajan, K., Reddi, B. A. J., Raj, J. P., Chapman, M. J., Horowitz, M., & Deane, A. M. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3287-7 · Cited by 227
“Given observations from prospective multi-centre interventional studies of larger sample populations, marked hyperglycaemia should still be considered as harmful in patients without pre-existing diabetes, and in patients with ‘stringently’ or ‘adequately controlled’ diabetes [16, 18, 19].”
BackgroundEgi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Journal of Intensive Care · doi:10.1186/s40560-021-00555-7 · Cited by 224
Finfer, S., Wernerman, J., Preiser, J.-C., Cass, T., Desaive, T., Hovorka, R., Joseph, J. I., Kosiborod, M., Krinsley, J., Mackenzie, I., et al. (2013) · Critical Care · doi:10.1186/cc12537 · Cited by 208
“Subsequent trials have used a variety of methods to measure the blood glucose concentration, which have included single specifi ed bedside glucose meters [6,7] or combined methods using specifi ed or unspecifi ed glucose meters and blood gas analyzers variably both within and between sites in multicenter trials [8,9].”
Self-citationKavanagh, B. P., & McCowen, K. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1001115 · Cited by 205
Tight Glycemic Control in Critically Ill Children
Agus, M. S. D., Wypij, D., Hirshberg, E. L., Srinivasan, V., Faustino, E. V., Luckett, P. M., Alexander, J. L., Asaro, L. A., Curley, M. A. Q., Steil, G. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612348 · Cited by 204
We should abandon randomized controlled trials in the intensive care unit
Vincent, J.-L. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181f208ac · Cited by 185
Florkowski, C., Don-Wauchope, A., Gimenez, N., Rodriguez-Capote, K., Wils, J., & Zemlin, A. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1399336 · Cited by 189
“The trial was also terminated early due to lack of benefit and increased hypoglycemia in the treated group [63].”
BackgroundHonarmand, K., Sirimaturos, M., Hirshberg, E. L., Bircher, N. G., Agus, M. S. D., Carpenter, D. L., Downs, C. R., Farrington, E. A., Freire, A. X., Grow, A., et al. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006174 · Cited by 202
Self-citationMild hypoglycemia is independently associated with increased mortality in the critically ill
Krinsley, J. S., Schultz, M. J., Spronk, P. E., Harmsen, R. E., van Braam Houckgeest, F., van der Sluijs, J. P., Mélot, C., & Preiser, J. C. (2011) · Critical Care · doi:10.1186/cc10322 · Cited by 178
“Additional differences between the NL-L and NL-S cohorts included the exclusive use of arterial blood for measurement of BG in the IIT group, and significantly higher glycemic variability, as reflected by CV and SD, in the NL-S cohort.”
BackgroundMethodInfluentialSelf-citationYamada, T., Shojima, N., Noma, H., Yamauchi, T., & Kadowaki, T. (2017) · Intensive Care Medicine · doi:10.1007/s00134-016-4523-0 · Cited by 171
Garg, R., Hurwitz, S., Turchin, A., & Trivedi, A. (2013) · Diabetes Care · doi:10.2337/dc12-1296 · Cited by 176
Krinsley, J. S., & Preiser, J.-C. (2015) · Critical Care · doi:10.1186/s13054-015-0908-7 · Cited by 174
“Subsequent interventional trials failed to reproduce these impressive findings [2,3,10,11].”
BackgroundResultInfluentialSelf-citationMonitoring nutrition in the ICU
Berger, M. M., Reintam-Blaser, A., Calder, P. C., Casaer, M., Hiesmayr, M. J., Mayer, K., Montejo, J. C., Pichard, C., Preiser, J.-C., van Zanten, A. R. H., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.07.009 · Cited by 171
Self-citationPerioperative glycaemic control for diabetic patients undergoing surgery
Buchleitner, A. M., Martínez-Alonso, M., Hernández, M., Solà, I., & Mauricio, D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007315.pub2 · Cited by 168
Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis
Kramer, A. H., Roberts, D. J., & Zygun, D. A. (2012) · Critical Care · doi:10.1186/cc11812 · Cited by 170
A.S.P.E.N. Clinical Guidelines: Nutrition Support of Adult Patients With Hyperglycemia
McMahon, M. M., Nystrom, E., Braunschweig, C., Miles, J., Compher, C., & the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112452001 · Cited by 164
“However, more recent large clinical trials failed to show benefit when such an aggressive target was achieved.(25,27-31,35) The largest randomized controlled trial that used primarily enteral nutrition at levels of energy intake that were appropriate actually found a higher mortality in patients treated with intensive…”
BackgroundTight blood-glucose control without early parenteral nutrition in the ICU
Gunst, J., Debaveye, Y., Güiza, F., Dubois, J., De Bruyn, A., Dauwe, D., De Troy, E., Casaer, M. P., De Vlieger, G., Haghedooren, R., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2304855 · Cited by 163
The NICE-SUGAR Study Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group and the Canadian Critical Care Trials Group (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3757-6 · Cited by 159
Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial
Kalfon, P., Giraudeau, B., Ichaï, C., Guerrini, A., Bréchot, N., Cinotti, R., Dequin, P., Riu-Poulenc, B., Montravers, P., Annane, D., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-013-3189-0 · Cited by 174
“gested that the difference in outcome between the two Leuven studies [4, 9] and subsequent RCTs [10–13] could be related to the excessive calories provided parenterally”
ResultSelf-citationBench-to-bedside review: Glucose and stress conditions in the intensive care unit
Losser, M.-R., Damoisel, C., & Payen, D. M. (2010) · Critical Care · doi:10.1186/cc9100 · Cited by 169
Santacruz, C. A., Pereira, A. J., Celis, É., & Vincent, J. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004000 · Cited by 160
Glucose variability measures and their effect on mortality: a systematic review
Eslami, S., Taherzadeh, Z., Schultz, M. J., & Abu–Hanna, A. (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2129-5 · Cited by 162
“Some studies showed that their implementation of glucose control with insulin comes with the risk of hypoglycemia [6, 7], others did not [8, 9].”
BackgroundContinuous glucose monitoring in the ICU: clinical considerations and consensus
Krinsley, J. S., Chase, J. G., Gunst, J., Martensson, J., Schultz, M. J., Taccone, F. S., Wernerman, J., Bohe, J., De Block, C., Desaive, T., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1784-0 · Cited by 145
Self-citationPathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action
Draznin, B., Gilden, J., Golden, S. H., Inzucchi, S. E., & for the PRIDE investigators (2013) · Diabetes Care · doi:10.2337/dc12-2508 · Cited by 145
Glycemic control in non-diabetic critically ill patients
Farrokhi, F., Smiley, D., & Umpierrez, G. E. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.05.004 · Cited by 138
Mifsud, S., Schembri, E. L., & Gruppetta, M. (2018) · British Journal of Hospital Medicine · doi:10.12968/hmed.2018.79.11.634 · Cited by 150
Sechterberger, M. K., Bosman, R. J., Oudemans-van Straaten, H. M., Siegelaar, S. E., Hermanides, J., Hoekstra, J. B., & De Vries, J. H. (2013) · Critical Care · doi:10.1186/cc12572 · Cited by 128
“Unfortunately, these trials have produced conflicting data, with some of the studies showing lower and others higher mortality with strict glucose control, the latter possibly due to an increased incidence of hypoglycaemia [7-12].”
ResultOrgan failure and tight glycemic control in the SPRINT study
Chase, J. G., Pretty, C. G., Pfeifer, L., Shaw, G. M., Preiser, J.-C., Le Compte, A. J., Lin, J., Hewett, D., Moorhead, K. T., & Desaive, T. (2010) · Critical Care · doi:10.1186/cc9224 · Cited by 130
“A literature survey shows that this cut-off value is well below mean or median reported values for admission or long-term average scores in several studies and is thus indicative of relatively well patients [5,27,42,49-52].”
BackgroundResultSelf-citationChase, J. G., Compte, A. J. L., Suhaimi, F. M., Shaw, G. M., Lynn, A. M., Lin, J., Pretty, C. G., Razak, N. N. A., Parente, J. D., Hann, C. E., et al. (2010) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2010.11.006 · Cited by 141
“However, most other reported protocols do not account for or assess insulin sensitivity in any way [3, 32, 33, 40-42, 44-46, 51, 68, 77, 81, 109-119], including the recent, major RCTs.”
InfluentialSelf-citationS3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00685-0 · Cited by 148
van Rooijen, S. J., Huisman, D. E., Stuijvenberg, M., Stens, J., Roumen, R. M. H., Daams, F. D., & Slooter, G. D. (2016) · International Journal of Surgery · doi:10.1016/j.ijsu.2016.09.098 · Cited by 143
STAR Development and Protocol Comparison
Fisk, L., Compte, A. J. L., Shaw, G. M., Penning, S., Desaive, T., & Chase, J. G. (2012) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2012.2214384 · Cited by 134
“Protocol simplicity and transparency are optimized to increase compliance, which can have a major impact on results [15], [22], signifying the importance of this work.”
BackgroundMethodInternational recommendations for glucose control in adult non diabetic critically ill patients
Ichai, C., Preiser, J.-C., (SFAR), F. T. S. F. D.-R., & Société de Réanimation de langue Française (SRLF) and the Experts group (2010) · Critical Care · doi:10.1186/cc9258 · Cited by 127
“However, there is no study that can be used as a basis to recommend any given interval between measurements as a function of the equilibrium observed: from 30 minutes (in cases of hypoglycemia or severe hyperglycemia) to 4 hours depending upon glucose level stability and study [4,15-19].”
BackgroundMethodResultInfluentialSelf-citationInsulin Therapy for the Management of Hyperglycemia in Hospitalized Patients
McDonnell, M. E., & Umpierrez, G. E. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.01.001 · Cited by 117
Validation of a model-based virtual trials method for tight glycemic control in intensive care
Chase, J. G., Suhaimi, F. M., Penning, S., Preiser, J., Compte, A. J. L., Lin, J., Pretty, C. G., Shaw, G. M., Moorhead, K. T., & Desaive, T. (2010) · BioMedical Engineering OnLine · doi:10.1186/1475-925x-9-84 · Cited by 133
“Glucontrol was a multi-centre study stopped early due to a high rate of unintended protocol violations [26].”
BackgroundMethodInfluentialSelf-citationHyperglycemia and Perioperative Glucose Management
E. Duncan, A. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803832236 · Cited by 119
“Indeed, several reports have found hypoglycemia to be an independent risk factor for death [11, 66, 68].”
BackgroundLeelarathna, L., English, S. W., Thabit, H., Caldwell, K., Allen, J. M., Kumareswaran, K., Wilinska, M. E., Nodale, M., Mangat, J., Evans, M. L., et al. (2013) · Critical Care · doi:10.1186/cc12838 · Cited by 120
“The extent to which hyperglycemia in critical illness should be corrected has been the focus of number of prospective studies [12-16] with conflicting results and remains the subject of an ongoing debate [17].”
BackgroundSchricker, T., & Lattermann, R. (2015) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-014-0274-y · Cited by 139
“It is particularly interesting that most ‘‘glycemic control studies’’ after Leuven-I were unable to establish and preserve a normal blood glucose level.(74,76,78) Therefore, the conclusions that studies failing to reach this target reported regarding the clinical benefits of normoglycemia are questionable.”
BackgroundIntensive versus intermediate glucose control in surgical intensive care unit patients
Okabayashi, T., Shima, Y., Sumiyoshi, T., Kozuki, A., Tokumaru, T., Iiyama, T., Sugimoto, T., Kobayashi, M., Yokoyama, M., & Hanazaki, K. (2014) · Diabetes Care · doi:10.2337/dc13-1771 · Cited by 119
Singer (2009) · doi:10.1016/j.clnu.2013.12.004 · Cited by 118
Self-citationEnhanced Recovery After Surgery: It's Time to Change Practice!
Steenhagen, E. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615622640 · Cited by 141
Type 2 diabetes mellitus and sepsis: state of the art, certainties and missing evidence
Costantini, E., Carlin, M., Porta, M., & Brizzi, M. F. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01728-4 · Cited by 131
“Two further large-scale trials including mixed populations of medical and surgical patients, the Glucontrol study [47] and the Normoglyce-”
BackgroundPathophysiologic mechanisms in septic shock
King, E. G., Bauzá, G., Mella, J. R., & Remick, D. G. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.110 · Cited by 127
Brodovicz, K. G., Mehta, V., Zhang, Q., Zhao, C., Davies, M. J., Chen, J., Radican, L., & Engel, S. S. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.754744 · Cited by 112
Barazzoni, R., Deutz, N. E. P., Biolo, G., Bischoff, S., Boirie, Y., Cederholm, T., Cuerda, C., Delzenne, N., Leon Sanz, M., Ljungqvist, O., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.09.010 · Cited by 112
Self-citationPost-cardiac arrest brain injury: Pathophysiology and treatment
Chalkias, A. F., & Xanthos, T. T. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.12.007 · Cited by 108
Nishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Journal of Intensive Care · doi:10.1186/s40560-017-0270-8 · Cited by 118
Endocrine Responses to Critical Illness: Novel Insights and Therapeutic Implications
Boonen, E., & Van den Berghe, G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4115 · Cited by 105
Farhan, H. N., Moreno‐Duarte, I., Latronico, N., ZAFONTE, R. D., & Eikermann, M. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000874 · Cited by 122
Penack, O., Becker, C., Buchheidt, D., Christopeit, M., Kiehl, M. G., von Lilienfeld‐Toal, M., Hentrich, M., Reinwald, M., Salwender, H. J., Schalk, E., et al. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2086-0 · Cited by 117
“Results of clinical trials in patients with severe sepsis and septic shock [13, 32] as well as clinical trials [51, 133, 158] including patients with underlying malignant disease [158] and a meta-analysis [61] in mixed populations of critically ill patients failed to show a benefit of intensified insulin therapy.”
BackgroundGlycaemic control targets after traumatic brain injury: a systematic review and meta-analysis
Hermanides, J., Plummer, M. P., Finnis, M., Deane, A. M., Coles, J., & Menon, D. K. (2018) · Critical Care · doi:10.1186/s13054-017-1883-y · Cited by 100
“This observation is consistent with results from the broader neurocritical care population [32, 33] and multicentre studies of heterogeneous mixed medical/surgical populations [9, 10, 29, 34].”
MethodResultKrinsley, J. S., Meyfroidt, G., den Berghe, G. V., Egi, M., & Bellomo, R. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834f0009 · Cited by 100
“Incorrect estimations of blood glucose value, especially in the hypoglycemia range, may have led to inappropriate insulin dosing in interventional trials [3,6] resulting in increased glycemic variability and hypoglycemia.”
BackgroundAbdelmalak, B., Knittel, J. G., Abdelmalak, J. B., Dalton, J. E., Christiansen, E. H., Foss, J. F., ARGALIOUS, M. Y., Zimmerman, R. S., & den Berghe, G. V. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet297 · Cited by 109
LOGIC-Insulin Algorithm–Guided Versus Nurse-Directed Blood Glucose Control During Critical Illness
Van Herpe, T., Mesotten, D., Wouters, P. J., Herbots, J., Voets, E., Buyens, J., De Moor, B., & Van den Berghe, G. (2013) · Diabetes Care · doi:10.2337/dc12-0584 · Cited by 95
The metrics of glycaemic control in critical care
Mackenzie, I. M. J., Whitehouse, T., & Nightingale, P. (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2103-2 · Cited by 594
“For example, it is well known that TGC increases the risk of hypoglycaemia [7, 8, 13, 44, 45], but it has also been shown that such a protocol may reduce measures of central tendency at the expense of an increase in measures of variability [18, 28].”
BackgroundGlycaemic control in the perioperative period
Sebranek, J. J., Lugli, A. K., & Coursin, D. B. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet381 · Cited by 101
The optimal target for acute glycemic control in critically ill patients: A network meta-analysis.
Yatabe, T., Inoue, S., Sakaguchi, M., & Egi, M. (2017) · Intensive Care Medicine · doi:10.1007/s00134-016-4558-2 · Cited by 95
Pilot proof of concept clinical trials of Stochastic Targeted (STAR) glycemic control
Evans, A., Shaw, G. M., Compte, A. L., Tan, C.-S., Ward, L., Steel, J., Pretty, C. G., Pfeifer, L., Penning, S., Suhaimi, F. M., et al. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-38 · Cited by 99
“Per patient, the median [IQR] hours of TGC was 92 h [29-113] using 53 [19-62] measurements (median, ~13/day).”
BackgroundMethodInfluentialLanspa, M. J., Dickerson, J., Morris, A. H., Orme, J. F., Holmen, J. R., & Hirshberg, E. L. (2014) · Critical Care · doi:10.1186/cc13851 · Cited by 98
“Subsequent studies evaluating the role of insulin therapy in the ICU either failed to confirm these results, or were terminated early due to high hypoglycemia rates [2-6].”
ResultAn Overview of Hypoglycemia in the Critically Ill
Lacherade, J.-C., Jacqueminet, S., & Preiser, J.-C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300603 · Cited by 86
Self-citationUnderstanding hypoglycemia in hospitalized patients
Hulkower, R. D., Pollack, R. M., & Zonszein, J. (2014) · Diabetes Management · doi:10.2217/dmt.13.73 · Cited by 89
Egi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Acute Medicine & Surgery · doi:10.1002/ams2.659 · Cited by 96
Pretty, C. G., Compte, A. J. L., Chase, J. G., Shaw, G. M., Preiser, J., Penning, S., & Desaive, T. (2012) · Annals of Intensive Care · doi:10.1186/2110-5820-2-17 · Cited by 99
“This situation may provoke larger insulin doses from many protocols that have no explicit upper limits on insulin dose [6,30-32].”
BackgroundSelf-citationBohé, J., Abidi, H., Brunot, V., Klich, A., Klouche, K., Sédillot, N., Tchénio, X., Quenot, J., Roudaut, J.-B., Mottard, N., et al. (2021) · PubMed Central · doi:10.1007/s00134-021-06526-8 · Cited by 88
Self-citationEgi, M., Finfer, S. R., & Bellomo, R. (2011) · CHEST Journal · doi:10.1378/chest.10-1478 · Cited by 95
Metadata
- Authors
- Preiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., Wernerman, J., Joannidis, M., Stecher, A., & Chioléro, R.
- Affiliations
- Centre Hospitalier Universitaire de Liège (BE)
- Erasmus Hospital (BE)
- Hôpital Raymond-Poincaré (FR)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- University of Milan (IT)
- Université Joseph Fourier (FR)
- Institut Gustave Roussy (FR)
- Rabin Medical Center (IL)
- Karolinska Institutet (SE)
- Universität Innsbruck (AT)
- Ljubljana University Medical Centre (SI)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Preiser, Jean-Charles
- ORCID
- Venue
- Intensive Care Medicine
- Published
- 2009-07-28
- Volume
- 35
- Issue
- 10
- Pages
- 1738-1748
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2139706988
- Cited by
- 911
- References
- 37
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 24 · 2023: 33 · 2022: 23 · 2021: 32 · 2020: 31 · 2019: 48 · 2018: 48 · 2017: 46 · 2016: 57 · 2015: 69 · 2014: 80 · 2013: 76 · 2012: 95
- FWCI
- 75.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- Acceda (Universidad de Las Palmas de Gran Canaria) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Universidad de Las Palmas de Gran Canaria
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- intensive insulin therapy, tight glycemic control, glycemic targets, critically ill adults, intensive care unit, ICU mortality, hypoglycemia, insulin therapy, early trial termination, protocol violations, time in target glucose range, ICU length of stay, cost-effectiveness, quality of life
- MeSH terms
- Aged, Blood Glucose, Female, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Intensive Care Units, Male, Middle Aged, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.